retatrutide 3 receptors How Does Work? Triple Agonist Explained tirzepatide receptors Retatrutide vs Tirzepatide:

You start at a lower dose and increase it over several weeks

Weight Loss Results with Rybelsus: While not FDA-approved for weight loss, clinical trials showed: 3 mg dose: 1-2% body weight loss 7 mg dose: 2-3% body weight loss 14 mg dose: 3-5% body weight loss Compare to injectable semaglutide (Wegovy): 2.4 mg weekly injection: 10-15% body weight loss The difference: Injectable semaglutide produces 3-5 times more weight loss than oral semaglutide at maximum doses

Statistical methods Baseline characteristics were summarized at the time of treatment initiation

The company is developing several compounds that address different patient populations and offer unique benefits

You can see some of the photos on Instagram, but Im bringing it up here because, of course, theres a diabetes tie-in